Taiwan Tati Cultural and Educational Foundation

 
  • Increase font size
  • Default font size
  • Decrease font size
Home The News News

News

Taiwan must build consensus: Bush

Former American Institute in Taiwan (AIT) chairman Richard Bush said in Taipei yesterday that it is important to build a consensus in Taiwan about its core interests so that the country can face the challenges that lie ahead.

The former AIT head, who now serves as the director of the Center for Northeast Asia Policy Studies at the Brookings Institution, made the remark at an international conference titled “A Spectacular Century: The Republic of China (ROC) Centennial Democracy Forums.”

The two-day conference was organized by the Council for Cultural Affairs as part of a year-long celebration of the country’s 100th anniversary.

Read more...
 
 

Experts call for US, China policy shift to avoid war

Experts told a conference in Washington on Wednesday that to avoid war over Taiwan, Beijing and Washington must change their current policies.

“China must renounce the use of force against Taiwan or Washington must declare clearly, unequivocally and publicly that it will defend Taiwan against Chinese attack,” said Joseph Bosco, who served in the office of the US secretary of defense as a China country desk officer in 2005 and 2006.

The US, China and Taiwan urgently need a “declaration of strategic clarity,” he said.

Quoting former US secretary of state Henry Kissinger, Bosco said that while ambiguity was sometimes the lifeblood of diplomacy, it could not be maintained indefinitely.

Read more...
 


Page 1129 of 1488

Newsflash

The WHO’s addition of Medigen Vaccine Biologics Corp’s (高端疫苗) COVID-19 vaccine to its pool marks the first time the world body has authorized a Taiwan-made vaccine and it is an endorsement of the country’s vaccine industry, Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) said yesterday.

Medigen on Tuesday announced an out-licensing agreement with the WHO’s COVID-19 Technology Access Pool (C-TAP) and the UN-backed Medicines Patent Pool, which makes its vaccine technology available to people in need worldwide.